Am J Health-Syst Pharm
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Order Full text via Infotrieve
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ferriols-Lisart, R
Right arrow Articles by Alos-Alminana, M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ferriols-Lisart, R
Right arrow Articles by Alos-Alminana, M
American Journal of Health-System Pharmacy, Vol 53, Issue 10, 1141-1150
Copyright © 1996 by American Society of Health-System Pharmacists

Articles

Effectiveness and safety of once-daily aminoglycosides: a meta-analysis

R Ferriols-Lisart and M Alos-Alminana


The effectiveness and safety of once-daily versus several-times-daily aminoglycosides were studied in a meta-analysis. MEDLINE for 1988 to 1995 was searched, and additional studies were identified from review articles and references in retrieved articles. Studies selected for meta-analysis were randomized controlled clinical trials in nonneutropenic adult patients comparing the clinical effectiveness or nephrotoxicity or ototoxicity of once-daily with several-times-daily aminoglycosides. Differences between groups were expressed as odds ratios. The results were combined by the procedure of Mantel and Haenszel, and 95% confidence intervals and exact confidence intervals were computed. An odds ratio smaller than 1 would indicate a lesser likelihood of a given endpoint in the once-daily group, and an odds ratio greater than 1 would indicate a greater likelihood. Eighteen studies involving 2317 patients were included in the meta-analysis. Summary odds ratios were 1.47 for effectiveness (95% CI = 1.13-1.94), 0.56 for ototoxicity (95% CI = 0.26-1.16), and 0.60 for nephrotoxicity (95% CI = 0.40-0.86). A meta-analysis showed that treatment with single daily doses of aminoglycosides seems to be more effective, less nephrotoxic, and as ototoxic as multiple doses daily.
 



This article has been cited by other articles:


Home page
 The Annals of PharmacotherapyHome page
R. E Ariano, S. A Zelenitsky, and D. A Kassum
Aminoglycoside-Induced Vestibular Injury: Maintaining a Sense of Balance
Ann. Pharmacother., September 1, 2008; 42(9): 1282 - 1289.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
L. Sung, L. L. Dupuis, B. Bliss, A. Taddio, M. Abdolell, U. Allen, M. Rolland, A. Tong, T. Taylor, and J. Doyle
Randomized Controlled Trial of Once- Versus Thrice-Daily Tobramycin in Febrile Neutropenic Children Undergoing Stem Cell Transplantation
J Natl Cancer Inst, December 17, 2003; 95(24): 1869 - 1877.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
J. D. Kopple, H. Ding, A. Letoha, B. Ivanyi, D. P.-Y. Qing, L. Dux, H.-Y. Wang, and S. Sonkodi
L-carnitine ameliorates gentamicin-induced renal injury in rats
Nephrol. Dial. Transplant., December 1, 2002; 17(12): 2122 - 2131.
[Abstract] [Full Text] [PDF]

Home page
 DTBHome page
Aminoglycosides once daily?
DTB, May 1, 1997; 35(5): 36 - 37.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the American Society of Health-System Pharmacists.